N-Nitroso Fluvoxamine EP Impurity K
N-Nitroso Fluvoxamine EP Impurity K is a specific impurity associated with the drug fluvoxamine, which is an antidepressant medication. In pharmaceutical contexts, impurities like N-Nitroso Fluvoxamine EP Impurity K are closely monitored because they can affect the efficacy, safety, and stability of the drug product.Pharmaceutical companies use analytical methods to monitor and control the levels of N-Nitroso Fluvoxamine EP Impurity K during the manufacturing process and in finished drug products.
N-Nitroso Fluvoxamine EP Impurity K CAS NO:NA also Known as N-Nitroso Fluvoxamine Impurity K chemically represented as (E)-N-(2-aminoethyl)-N-(2-(((1-(4-(trifluoromethyl)phenyl)pentylidene)amino)oxy)ethyl)nitrous amide. Synchemia is the leading manufacturing and exporter of N-Nitroso Fluvoxamine EP Impurity K . We supply N-Nitroso Fluvoxamine EP Impurity K with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142292 |
| CAS No | NA |
| Mol.F. | C16H13ClN4O2 |
| Mol.Wt. | 328.76 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142293 |
| CAS No | NA |
| Mol.F. | C18H15ClN4O2 |
| Mol.Wt. | 354.79 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142294 |
| CAS No | NA |
| Mol.F. | C16H13ClN4O2 |
| Mol.Wt. | 328.76 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142295 |
| CAS No | NA |
| Mol.F. | C20H21ClN4O3 |
| Mol.Wt. | 400.86 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142296 |
| CAS No | NA |
| Mol.F. | C18H19ClN4O2 |
| Mol.Wt. | 358.83 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142297 |
| CAS No | NA |
| Mol.F. | C17H15ClN4O3 |
| Mol.Wt. | 358.78 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142298 |
| CAS No | NA |
| Mol.F. | C17H15ClN4O3 |
| Mol.Wt. | 358.78 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142299 |
| CAS No | NA |
| Mol.F. | C17H17ClN4O3 |
| Mol.Wt. | 360.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142300 |
| CAS No | NA |
| Mol.F. | C17H17ClN4O3 |
| Mol.Wt. | 360.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142301 |
| CAS No | NA |
| Mol.F. | C13H7ClN2O3 |
| Mol.Wt. | 274.66 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142302 |
| CAS No | NA |
| Mol.F. | C16H18N4O6S |
| Mol.Wt. | 394.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142303 |
| CAS No | NA |
| Mol.F. | C16H20N4O7S |
| Mol.Wt. | 412.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142304 |
| CAS No | NA |
| Mol.F. | C15H20N4O5S |
| Mol.Wt. | 368.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142305 |
| CAS No | NA |
| Mol.F. | C48H55N11O17S3 |
| Mol.Wt. | 1154.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142306 |
| CAS No | NA |
| Mol.F. | C32H38N8O13S2 |
| Mol.Wt. | 806.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142307 |
| CAS No | NA |
| Mol.F. | C31H39N7O10S2 |
| Mol.Wt. | 733.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |